Resultados de búsqueda - Panagiotis A. Konstantinopoulos

Limitar resultados
  1. 1
    From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation

    From checkpoint to checkpoint: DNA damage ATR/Chk1 checkpoint signalling elicits PD-L1 immune checkpoint activation por Kent W. Mouw, Panagiotis A. Konstantinopoulos

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  2. 2
    PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers

    PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers por Elizabeth K. Lee, Panagiotis A. Konstantinopoulos

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair

    PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair por Panagiotis A. Konstantinopoulos, Stéphanie Lheureux, Kathleen N. Moore

    Publicado 2020
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis

    Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis por Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos, Athanasios G. Papavassiliou

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations

    Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations por Jennifer Veneris, Ursula A. Matulonis, Joyce F. Liu, Panagiotis A. Konstantinopoulos

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  6. 6
    Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer

    Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer por Panagiotis A. Konstantinopoulos, Andrew J. Wilson, Jeanette Saskowski, Erica Wass, Dineo Khabele

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

    Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer por Panagiotis A. Konstantinopoulos, Raphaël Ceccaldi, Geoffrey I. Shapiro, Alan D. D’Andrea

    Publicado 2015
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  8. 8
    Biomarkers of Response and Resistance to DNA Repair Targeted Therapies

    Biomarkers of Response and Resistance to DNA Repair Targeted Therapies por Elizabeth H. Stover, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, Elizabeth M. Swisher

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  9. 9
    DNA Damage and Repair Biomarkers of Immunotherapy Response

    DNA Damage and Repair Biomarkers of Immunotherapy Response por Kent W. Mouw, Michael S. Goldberg, Panagiotis A. Konstantinopoulos, Alan D. D’Andrea

    Publicado 2017
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  10. 10
    Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates

    Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates por Wojciech Fendler, Beata Małachowska, Khyati Meghani, Panagiotis A. Konstantinopoulos, Chandan Guha, Vijay K. Singh, Dipanjan Chowdhury

    Publicado 2017
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

    Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001) por Panagiotis A. Konstantinopoulos, William E. Brady, John Farley, Amy E. Armstrong, Denise Uyar, David M. Gershenson

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma

    Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma por Elizabeth H. Stover, Colleen M. Feltmate, Ross S. Berkowitz, Neal I. Lindeman, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability

    MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability por Young Eun Choi, Yunfeng Pan, Eunmi Park, Panagiotis A. Konstantinopoulos, Subhajyoti De, Alan D. D’Andrea, Dipanjan Chowdhury

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Resistance to therapy in <i>BRCA2</i> mutant cells due to loss of the nucleosome remodeling factor CHD4

    Resistance to therapy in <i>BRCA2</i> mutant cells due to loss of the nucleosome remodeling factor CHD4 por Shawna Guillemette, Ryan W. Serra, Min Peng, Janelle A. Hayes, Panagiotis A. Konstantinopoulos, Michael R. Green, Sharon B. Cantor

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer

    Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer por Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Elena Fountzilas, Nancy Francoeur, Srisowmya Sanisetty, Alexandros P. Grammatikos, Jonathan L. Hecht, Stephen A. Cannistra

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

    Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer por Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Beth Y. Karlan, Toshiyasu Taniguchi, Elena Fountzilas, Nancy Francoeur, Douglas A. Levine, Stephen A. Cannistra

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells

    PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells por Chiara Bellio, Celeste M. DiGloria, Rosemary Foster, Kaitlyn E. James, Panagiotis A. Konstantinopoulos, Whitfield B. Growdon, Bo R. Rueda

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance

    A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance por Raphaël Ceccaldi, Kevin W. O’Connor, Kent W. Mouw, Adam Y. Li, Ursula A. Matulonis, Alan D. D’Andrea, Panagiotis A. Konstantinopoulos

    Publicado 2015
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells

    Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells por Young Eun Choi, Chiara Battelli, Jacqueline Watson, Joyce F. Liu, Jennifer Curtis, Alexander Morse, Ursula A. Matulonis, Dipanjan Chowdhury, Panagiotis A. Konstantinopoulos

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Complications of pelvic radiation in patients treated for gynecologic malignancies

    Complications of pelvic radiation in patients treated for gynecologic malignancies por Akila N. Viswanathan, Larissa J. Lee, Jairam R. Eswara, Neil S. Horowitz, Panagiotis A. Konstantinopoulos, Kristina Mirabeau-Beale, Brent S. Rose, Arvind von Keudell, Jennifer Y. Wo

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: